These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 26817256)

  • 21. Efficacy of visual inspection of the cervix using acetic acid in cervical cancer screening: a comparison with cervical cytology.
    Akinola OI; Fabamwo AO; Oshodi YA; Banjo AA; Odusanya O; Gbadegesin A; Tayo A
    J Obstet Gynaecol; 2007 Oct; 27(7):703-5. PubMed ID: 17999297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical Cancer Screening in Developing Countries: Using Visual Inspection Methods.
    Lee H; Kang Y; Ju W
    Clin J Oncol Nurs; 2016 Feb; 20(1):79-83. PubMed ID: 26800410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical cytology practice guideline. American Society of Cytopathology.
    Diagn Cytopathol; 2001 Jul; 25(1):3-24. PubMed ID: 11466809
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of visual inspection of cervix and Pap smear for cervical cancer screening.
    Tayyeb R; Khawaja NP; Malik N
    J Coll Physicians Surg Pak; 2003 Apr; 13(4):201-3. PubMed ID: 12718787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of cytological examination in diagnosis of precancer and cancer of the uterine cervix].
    Khinkova N; Tanchev L; Tsvetkov Ch; Strateva D; Gorchev G
    Akush Ginekol (Sofiia); 2010; 49(5):33-6. PubMed ID: 21268400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical cytology in Zambia.
    Grech ES; O'Dowd MJ; Tsirkina GA; Zeigler O
    Med J Zambia; 1977; 11(4):112-7. PubMed ID: 919781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Abnormal cervical cytology. Management without colposcope].
    Bernal Bastidas S; Panduro Baron JG; Valle España JE; Villagrán Lorenzana A
    Ginecol Obstet Mex; 1989 Jul; 57():190-2. PubMed ID: 2486949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
    Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
    Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical Cancer Screening Program by Visual Inspection: Acceptability and Feasibility in Health Insurance Companies.
    Horo AG; Didi-Kouko Coulibaly J; Koffi A; Tchounga B; Seni K; Aka KE; Kone M
    Obstet Gynecol Int; 2015; 2015():798453. PubMed ID: 26167178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CHAPTER 6 Secondary prevention of cervical cancer.
    Denny L; Sankaranarayanan R
    Int J Gynaecol Obstet; 2006 Nov; 94 Suppl 1():S65-S70. PubMed ID: 29644636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An assessment of the potential role of automatic devices in cytology screening.
    Melamed MR; Kamentsky LA
    Obstet Gynecol Surv; 1969 Jul; 24(7 Pt 2):914-26. PubMed ID: 5212437
    [No Abstract]   [Full Text] [Related]  

  • 33. The NHS Cervical Screening Programme criteria for evaluating cervical cytology: comparison of the new with the old.
    Dina R; Argamosa D
    Cytopathology; 2012 Dec; 23(6):349-52. PubMed ID: 23173803
    [No Abstract]   [Full Text] [Related]  

  • 34. Automated analysis of cervix images to grade the severity of cancer.
    Pallavi V; Payal K
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():3439-42. PubMed ID: 22255079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [CLINICAL PERFORMANCE OF DIFFERENT METHODS FOR CERVICAL SCREENING].
    Atanasova D; Zlatkov V
    Akush Ginekol (Sofiia); 2015; 54(6):3-9. PubMed ID: 26817256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
    Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
    J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [IS THERE A PLACE FOR VIA AND VILI IN OUR PRACTICE].
    Zlatkov V
    Akush Ginekol (Sofiia); 2016; 55 Suppl 1 Pt 2():29-35. PubMed ID: 27509667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic value of TruScreen, cytology and colposcopy].
    Atanassova D; Zlatkov V; Borisov S; Veleva G
    Akush Ginekol (Sofiia); 2013; 52(3):7-18. PubMed ID: 24283057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical digital photography for screening of uterine cervix cancer and its precursor lesions in developing countries.
    Hillmann Ede C; Dos Reis R; Monego H; Appel M; Hammes LS; Rivoire WA; Capp E
    Arch Gynecol Obstet; 2013 Jul; 288(1):183-9. PubMed ID: 23400355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for cervical cancer and human papilloma virus: Indian context.
    Deodhar KK
    Clin Lab Med; 2012 Jun; 32(2):193-205. PubMed ID: 22726999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.